LakeShore Biopharma (LSH) Form 6-K Summary

Material Event: LakeShore Biopharma Co., Ltd. announced it has entered into a definitive agreement for a going-private transaction.

• Transaction Details: The filing includes the Agreement and Plan of Merger dated November 4, 2025.
• Involved Parties: The merger involves Oceanpine Skyline Inc. and Oceanpine Merger Sub Inc.
• Investor Impact: This confirms a significant strategic change where the company intends to transition away from public listing status.

__Critical action for investors: Review Exhibits 99.1